EP
SNY icon

Evelyn Partners’s Sanofi SNY Stock Holding History

Evelyn Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Buy
+14,233
New +$636K ﹤0.01% 205

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Evelyn Partners's SNY Position: Q2 2026 in Review

Evelyn Partners opened a new position in Sanofi (SNY) in Q2 2026: 14,233 shares worth $607K. The stake represents ﹤0.01% of the portfolio and ranks #205 among its holdings.

679 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Evelyn Partners held 14,233 shares of Sanofi worth $607K as of Q2 2026.
  • Sanofi was a new Evelyn Partners position in Q2 2026.
  • Sanofi made up ﹤0.01% of Evelyn Partners's portfolio in Q2 2026, its #205 holding.
  • 679 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Evelyn Partners's 13F filing for Q2 2026, filed 7 Aug 2026.